Product Code: ETC6191119 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The in vivo small animal imaging market in Australia is growing steadily, fueled by biomedical research, oncology studies, and pharmaceutical trials. Academic and research institutions are increasingly adopting advanced imaging modalities like PET, CT, and MRI for preclinical research.
The small animal imaging in vivo market is growing in Australia due to increasing investments in preclinical research and biomedical studies. The use of advanced imaging modalities like micro-CT, micro-MRI, and optical imaging is enhancing disease modeling and drug development. Academic research institutions and biotech firms are key contributors to this markets expansion.
This market contends with high equipment costs and the need for specialized operators. Additionally, ethical concerns regarding animal testing and complex regulatory requirements for animal research limit widespread adoption of in vivo imaging technologies.
Australias research and academic ecosystem is a fertile ground for the small animal imaging in vivo market. Growing emphasis on preclinical trials and cancer research is driving demand for advanced imaging technologies. Investments in high-resolution imaging modalities like micro-CT, PET, and optical imaging for rodents and other lab animals can cater to universities, pharmaceutical companies, and CROs conducting biomedical research.
The market for small animal in vivo imaging is supported by government investments in medical and veterinary research. Grants from the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC) promote technological innovation in biomedical imaging. Regulatory oversight ensures compliance with animal welfare laws, administered through state jurisdictions and the Australian Code for the Care and Use of Animals for Scientific Purposes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Small Animal Imaging (In-vivo) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Small Animal Imaging (In-vivo) Market - Industry Life Cycle |
3.4 Australia Small Animal Imaging (In-vivo) Market - Porter's Five Forces |
3.5 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Small Animal Imaging (In-vivo) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in small animal imaging (in-vivo) technologies |
4.2.2 Increasing research activities in the field of preclinical imaging |
4.2.3 Growing demand for non-invasive imaging techniques in veterinary research |
4.3 Market Restraints |
4.3.1 High cost associated with small animal imaging (in-vivo) systems |
4.3.2 Limited availability of skilled professionals for operating advanced imaging equipment |
5 Australia Small Animal Imaging (In-vivo) Market Trends |
6 Australia Small Animal Imaging (In-vivo) Market, By Types |
6.1 Australia Small Animal Imaging (In-vivo) Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Micro-magnetic resonance imaging, 2021- 2031F |
6.1.4 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Optical imaging, 2021- 2031F |
6.1.5 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Nuclear Imaging, 2021- 2031F |
6.1.6 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Other Imaging Modalities, 2021- 2031F |
6.2 Australia Small Animal Imaging (In-vivo) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Monitoring treatment response, 2021- 2031F |
6.2.3 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Cancer cell detection, 2021- 2031F |
6.2.4 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Biomarkers, 2021- 2031F |
6.2.5 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Longitudinal studies, 2021- 2031F |
6.2.6 Australia Small Animal Imaging (In-vivo) Market Revenues & Volume, By Epigenetics, 2021- 2031F |
7 Australia Small Animal Imaging (In-vivo) Market Import-Export Trade Statistics |
7.1 Australia Small Animal Imaging (In-vivo) Market Export to Major Countries |
7.2 Australia Small Animal Imaging (In-vivo) Market Imports from Major Countries |
8 Australia Small Animal Imaging (In-vivo) Market Key Performance Indicators |
8.1 Adoption rate of new in-vivo imaging technologies in veterinary research |
8.2 Number of research publications utilizing small animal imaging techniques |
8.3 Investment in research and development of small animal imaging technologies |
9 Australia Small Animal Imaging (In-vivo) Market - Opportunity Assessment |
9.1 Australia Small Animal Imaging (In-vivo) Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Australia Small Animal Imaging (In-vivo) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Small Animal Imaging (In-vivo) Market - Competitive Landscape |
10.1 Australia Small Animal Imaging (In-vivo) Market Revenue Share, By Companies, 2024 |
10.2 Australia Small Animal Imaging (In-vivo) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |